Amanta Healthcare Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
AMANTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Amanta Healthcare Limited has submitted its annual promoter disclosure under SEBI (SAST) Regulation 31(4) for the year ended March 31, 2026. The disclosure was filed by Bhavesh G. Patel, who is both a promoter and Chairman & Managing Director of the company. In the declaration, the Promoter and Promoter Group explicitly confirm that they have NOT placed any encumbrance — directly or indirectly — on the shares or securities of Amanta Healthcare Limited during Financial Year 2025-26. This is a standard regulatory filing required annually from promoters of listed companies.
This is a positive signal for investors as it confirms promoters have not pledged their shares, meaning there is no immediate risk of forced selling due to margin calls or loan default triggers. The stock is not currently encumbered by promoter-level debt obligations.